SCHEMBL29473686

SCHEMBL29473686

CC(C)C[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ NMT2 O60551 1/20 0.47
▸ NMT1 P30419 1/20 0.47
▸ NPY1R P25929 1/20 0.46
▸ NPY2R P49146 1/20 0.46
▸ NPY4R P50391 1/20 0.46
▸ MME P08473 3/20 0.43
▸ CPB2 Q96IY4 5/20 0.43
▸ OPRK1 P41145 2/20 0.42
▸ ERAP2 Q6P179 1/20 0.42
▸ ERAP1 Q9NZ08 1/20 0.42
▸ LNPEP Q9UIQ6 1/20 0.42
▸ FURIN P09958 1/20 0.40
▸ PCSK6 P29122 1/20 0.40
▸ TLR2 O60603 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31343198 0.94 NPY1R (0.48) NMT2NMT1NPY1RNPY2RNPY4R
SCHEMBL31343258 0.94 NPY1R (0.48) NMT2NMT1NPY1RNPY2RNPY4R
SCHEMBL30484834 0.93 NPY4R (0.47) NMT2NMT1NPY1RNPY2RNPY4R
SCHEMBL30484831 0.92 NPY4R (0.46) NMT2NMT1NPY1RNPY2RNPY4R
SCHEMBL30484833 0.92 NPY4R (0.44) NMT2NMT1NPY1RNPY2RNPY4R
SCHEMBL30478747 0.92 NMT2 (0.49) NMT2NMT1NPY1RNPY2RNPY4R
SCHEMBL29473693 0.91 GRIN2D (0.44) NMT2NMT1NPY1RNPY2RNPY4R
SCHEMBL30484828 0.90 MME (0.47) NMT2NMT1NPY1RNPY2RNPY4R
SCHEMBL29886546 0.90 NMT1 (0.47) NMT2NMT1NPY1RNPY2RNPY4R
SCHEMBL31722954 0.89 NMT1 (0.43) NMT2NMT1MMECPB2TLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4216992-A1 PARTICLE COMPRISING AN RSV-F PROTEIN FOR USE IN RSV VACCINATION DBV Technologies (FR) 2023-08-02 — — EP disclosed
WO-2022063990-A1 PARTICLE COMPRISING AN RSV-F PROTEIN FOR USE IN RSV VACCINATION DBV TECHNOLOGIES (FR) 2022-03-31 — — WO disclosed
Send feedback